Allogeneic Stem Cell Transplant
Showing 26 - 50 of >10,000
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Busulfan test dose
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Hematologic Diseases Trial in Palo Alto (biological, device, drug)
Recruiting
- Hematologic Diseases
- Allogeneic Stem Cell Transplant
- +2 more
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Mar 25, 2022
Stress, Psychological, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Stress reduction
Completed
- Stress, Psychological
- Caregivers
- Stress reduction intervention
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Influence of Timing PTCy in AlloSCT
Not yet recruiting
- Cyclophosphamide Toxicity
- Allogenic Haematopoetic Transplantation
- (no location specified)
Jun 6, 2023
GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)
Recruiting
- GATA2
- +2 more
- Allogeneic HSCT
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Sickle Cell Disease, Beta Thalassemia Trial in New York (Busulfan, Fludarabine, Alemtuzumab)
Active, not recruiting
- Sickle Cell Disease
- Beta Thalassemia
- Busulfan
- +3 more
-
New York, New YorkMorgan Stanley Children's Hospital, New York-Presbyterian, Colum
Aug 12, 2021
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)
Not yet recruiting
- Multiple Myeloma
- Allogeneic Stem Cell Transplantation
- CARTemis-1
-
Santander, Cantabria, Spain
- +4 more
Aug 1, 2023
Immunodeficiency, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute (NCI) (drug, radiation,
Recruiting
- Immunodeficiency
- Hematopoietic Stem Cell Transplantation
- Post-Transplant Cyclophosphamide (PTCY)
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
Intestinal Microbiome Dynamics in Solid Organ and Stem Cell
Enrolling by invitation
- Transplantation Infection
- +4 more
- Intestinal microbiome new generation sequencing
-
Minsk, BelarusMinsk Scientific-Practical Center for Surgery, Transplantation a
Aug 28, 2022
Clostridium Difficile Infections, Stem Cell Transplant Complications Trial (Vancomycin, Placebo)
Not yet recruiting
- Clostridium Difficile Infections
- Stem Cell Transplant Complications
- Vancomycin
- Placebo
- (no location specified)
Feb 17, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Acute Myeloid Leukemia or MDS Trial in United States (APR-246)
Completed
- Acute Myeloid Leukemia or Myelodysplastic Syndromes
-
Tampa, Florida
- +6 more
Jan 18, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 10, 2023
Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)
Recruiting
- Acute Myeloid Leukemia
- CPX-351
- +5 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022
Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Tumor Trial in Houston (Recombinant
Active, not recruiting
- Allogeneic Hematopoietic Stem Cell Transplant Recipient
- Hematopoietic and Lymphoid Cell Neoplasm
- Recombinant Human Papillomavirus Nonavalent Vaccine
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Allogeneic Stem Cell Transplant, Viral Infection Trial in Cincinnati (Viral Specific T-cells (VSTs))
Active, not recruiting
- Allogeneic Stem Cell Transplant
- Viral Infection
- Viral Specific T-cells (VSTs)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
May 5, 2021
NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,
Recruiting
- NK-Cell Lymphoma
- +2 more
- Methotrexate
- +9 more
-
San Francisco, California
- +1 more
Sep 1, 2021
CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)
Not yet recruiting
- CMV Infection
- +2 more
- Virus specific T cells
- (no location specified)
Oct 4, 2023
GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)
Active, not recruiting
- Graft Versus Host Disease
- Hematopoietic/Lymphoid Cancer
- fludarabine phosphate
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)
Recruiting
- Leukemia
- +2 more
- Alpha Beta T cell depletion
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Oct 27, 2021
Allogeneic Stem Cell Transplantation Trial in Cincinnati (Xylitol, Placebo)
Not yet recruiting
- Allogeneic Stem Cell Transplantation
- Xylitol
- Placebo
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 28, 2022
Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +3 more
- Allogeneic Bone Marrow Transplantation
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022